Prof Benjamin Solomon
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
701 Scholarly works
19 Projects
HIGHLIGHTS
2026
Journal article
Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial
DOI: 10.1016/j.lungcan.2026.1093852026
Journal article
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis.
DOI: 10.1093/oncolo/oyag1372026
Journal article
Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials
DOI: 10.1016/j.jtho.2026.01.0012025
Research grants (ARC, NHMRC, MRFF)
Advancing Precision Medicine for Lung Cancer
2020
Journal article
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma
DOI: 10.1038/s41388-020-1357-62020
Research Grant
PRedicting the Population Health Economic IMpact of Current and New CAncer Treatments (PRIMCAT)
2020
Research grants (ARC, NHMRC, MRFF)
Delivering Personalised Medicine for Lung Cancer
RECENT SCHOLARLY WORKS
2026
Journal article
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy
DOI: 10.1016/j.ctro.2026.1011382026
Journal article
149TiP ROSETTA Lung-02: A global phase II/III, randomized, open-label trial of pumitamig, a PD-L1 × VEGF-A bispecific antibody, in combination with chemotherapy in patients (pts) with first-line non-small cell lung cancer
DOI: 10.1016/j.esmoop.2026.1064562026
Journal article
Brief Report: Alectinib With Salvage Platinum-Taxane Chemotherapy in a Pregnant Woman With ALK-Rearranged NSCLC and Rapid Disease Progression Followed by a Successful Pregnancy
DOI: 10.1016/j.jtho.2025.11.0122026
Journal article
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
DOI: 10.1158/1078-0432.CCR-25-43822026
Journal article
Long-term survival outcomes after biomarker-guided thromboprophylaxis in cancer: extended follow-up of the TARGET-TP randomised trial.
DOI: 10.1093/jnci/djag0652026
Journal article
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC
DOI: 10.1016/j.esmoop.2026.1060702026
Journal article
Global advances and future directions in lung cancer care: expert consensus and strategic priorities
DOI: 10.1016/j.esmoop.2025.106034
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
A Registry-Based Randomised Trial of Radiotherapy in Advanced Lung Cancer